Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
1.720
-0.010 (-0.58%)
At close: Dec 5, 2025, 4:00 PM EST
1.740
+0.020 (1.16%)
After-hours: Dec 5, 2025, 6:49 PM EST
Climb Bio Market Cap
Climb Bio has a market cap or net worth of $117.28 million as of December 5, 2025. Its market cap has decreased by -46.32% in one year.
Market Cap
117.28M
Enterprise Value
-57.97M
1-Year Change
-46.32%
Ranking
Category
Stock Price
$1.72
Market Cap Chart
Since August 10, 2021, Climb Bio's market cap has decreased from $403.20M to $117.28M, a decrease of -70.91%. That is a compound annual growth rate of -24.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 117.28M | -3.08% |
| Dec 31, 2024 | 121.00M | 62.54% |
| Dec 29, 2023 | 74.45M | -23.65% |
| Dec 30, 2022 | 97.50M | -64.90% |
| Dec 31, 2021 | 277.76M | -31.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |